Plain-English translation of NCT06574373 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying people with a condition called IPMN—pancreatic cysts that can sometimes turn into cancer—to find new biological markers (like specific genes or proteins) that signal when a cyst is becoming dangerous. By comparing samples from patients whose cysts stay stable, those whose cysts become cancerous, and those who already have pancreatic cancer, the team hopes to develop better tools to predict which patients need more aggressive monitoring or treatment.
Right now, doctors struggle to know which pancreatic cysts will become cancer and which ones won't. This uncertainty means some patients get unnecessary surgery, while others might miss early warning signs. This research aims to find reliable biological signals that can tell doctors exactly when a cyst is turning into cancer, so they can act faster and make better treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join, you would donate blood and tissue samples (either newly collected or archival samples from previous procedures), which researchers will analyze to look for biological markers. Your medical records will also be reviewed to track your disease course over time. The study involves 3,600 patients across multiple medical centers, so the exact details of your participation may vary depending on which center enrolls you, but the core involves providing samples and allowing researchers to study them.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy